title: Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis.
authors.forename: Alejandra
authors.initials: A
authors.lastname: Fernández
authors.forename: Antonio
authors.initials: A
authors.lastname: Velasco
authors.forename: Vanesa
authors.initials: V
authors.lastname: Prieto
authors.forename: Javier
authors.initials: J
authors.lastname: Canueto
authors.forename: Alberto
authors.initials: A
authors.lastname: Alvarez
authors.forename: Antonio
authors.initials: A
authors.lastname: Rodríguez
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D017511:Pyoderma Gangrenosum / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab